Tranexamic Acid Dosing Regimen for Brain Bleeds

Initial Management and Timing

For patients with brain bleeds, the American College of Critical Care recommends administering tranexamic acid (TXA) as a loading dose of 1 g intravenously over 10 minutes, followed by an infusion of 1 g over 8 hours, which should be administered as soon as possible after identification of intracranial hemorrhage, ideally within 3 hours of injury for maximum efficacy 1, 2, 3
Early administration is crucial, as treatment within the first hour of injury in patients with mild to moderate traumatic brain injury has shown the greatest benefit 1
The standard approach is to not wait for viscoelastic assessment results before administering TXA, as recommended by Critical Care guidelines 1

The standard dosing regimen of 1 g IV over 10 minutes, followed by 1 g IV over 8 hours, has been extensively studied and is recommended by Critical Care guidelines 1, 2, 3
For patients with renal impairment, dose adjustment is necessary as TXA is primarily eliminated through the kidneys, with consideration for reducing the maintenance dose in patients with GFR <50 ml/min, as suggested by Praxis Medical Insights 3

TXA appears most effective when administered within 3 hours of injury, as supported by Critical Care guidelines 1

Monitor for potential adverse effects such as thromboembolic events, especially in elderly patients, as cautioned by Praxis Medical Insights 2, 3

Evaluate clinical response through decreased bleeding and stabilization of hemoglobin levels, and monitor coagulation parameters in patients with massive bleeding, as recommended by Praxis Medical Insights 2, 3

If TXA is unavailable, ε-aminocaproic acid may be considered at a dose of 100-150 mg/kg followed by 15 mg/kg/hour, although TXA is preferred due to its more extensive evidence base in traumatic brain injury, as stated in Critical Care guidelines 1, 4

TXA should be part of a comprehensive approach to managing brain bleeds that includes appropriate blood pressure control and surgical intervention when indicated, as recommended by Critical Care guidelines 1
For patients on oral anticoagulants with brain bleeds, consider additional reversal strategies alongside TXA administration, as suggested by Praxis Medical Insights 2